Ñamendys-Silva S, Reyes-Ruiz M, Rivero-Sigarroa E, Domínguez CG

Language: Spanish
References: 26
Page: 468-472
PDF size: 220.41 Kb.

ABSTRACT

Introduction: Identification of risk factors for mortality has enabled improving the treatment of critically ill patients with systemic lupus erythematosus. Objective: To describe clinical characteristics and prognoses of critically ill patients with systemic lupus erythematosus admitted to an intensive care unit. Method: Prospective, observational cohort study. A total of 207 patients with systemic lupus erythematosus admitted between January 2011 and January 2016 were included. Results: During the study period, 3,215 critically ill patients were admitted to the intensive care unit, out of which 207 (6.4%) were identified as having systemic lupus erythematosus after being evaluated by an intensivist. The multivariate analysis identified the presence of organ failure (cardiovascular, liver, neurological) and serum lactate levels › 2 mmoL/L at admission or within the first 24 hours of intensive care unit stay as the main factors associated with increased mortality. Conclusions: A relevant observation was that neurological failure and liver failure were associated with higher mortality risk at 28 days, without reports similar to these findings being identified.

REFERENCES

1. David P, Munther A, Graham R. Systemic lupus erythematosus. Lancet. 2007;369 587-596.

2. Navarra S, Leynes M. Infections in systemic lupus erythematosus. Lupus. 2010;19:1419-1424

3. Han BK, Bhatia R, Traisak P, Hunter K, Schorr C, Eid H, et al. Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit. Lupus. 2013;22:690-696.

4. Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C, et al. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther. 2009;11 R109.

5. Pons-Estel GJ, Alarcón GS, Scofield L, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of Systemic Lupus Erythematosus. Semin Arthritis Rheum. 2010;39:257-268.

6. Danchemko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparation of worldwide disease burden. Lupus. 2006;15:308-318.

7. Souza DC, Santo AH, Sato EI. Mortality profile related to systemic lupus erythematous: a multiple cause-of-death analysis. J Rheumatol. 2012;39:496-503.

8. Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33 57-63.

9. Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus. 2007;16:997-1000.

10. Namendys-Silva SA, Baltazar-Torres JA, Rivero-Sigarroa E, Fonseca- Lazcano JA, Montiel-López L, Domínguez-Cherit G. Prognostic factors in patients with systemic lupus erythematosus admitted to intensive care unit. Lupus. 2009;18:1252-1258.

11. Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Brechot N, et al. Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest. 2015;148:927-935.

12. Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev. 2013; 12:380-395.

13. Siripaitoon B. Lertwises S. Uea-areewongsa P, et al. A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality. Lupus. 2015;24:98-106.

14. Mak A, Cheung M, Chiew H, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematous: meta-analisis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41:830-839.

15. Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic disease in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005;14:315-320.

16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13: 818-829.

17. Vincent JL, Moreno R, Takala J, Willatts S, De-Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-710.

18. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent, JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754-1758.

19. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.

20. Hess DR. Respiratory mechanics in mechanically ventilated patients. Respir Care. 2014;11:1773-1794.

21. Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY, et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care. 2005;9:R177-R183.

22. Kuroda Y. Neurocritical care update. J Intensive Care. 2016;4:36.

23. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787-1794.

24. Bhattacharyya S, Helfgott SM. Neurologic complications of systemic lupus erythematosus, Sjögren syndrome and rheumatoid arthritis. Semin Neurol. 2014;34:425-436.

25. Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42:202-210.

26. Juneja D, Singh O, Dang R. Admission hyperlactatemia: causes, incidence, and impact on outcome of patients admitted in general medical intensive care unit. J Crit Care. 2011;26:316-320.